Mengue Sotero Serrate, Tierling Vera Lúcia, Tavares Noemia Urruth Leão, Fontanella Andréia Turmina
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.
Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brasil.
Cad Saude Publica. 2022 Oct 17;38Suppl 1(Suppl 1):e00152721. doi: 10.1590/0102-311X00152721. eCollection 2022.
This study aims to analyze the sources people over 18 years of age use to obtain medication for the treatment of hypertension and diabetes, according to sociodemographic characteristics from 2013 to 2019. Data from the Brazilian National Health Survey were analyzed. Most individuals with diagnosis and prescription to pharmacological treatment reported obtaining medicines exclusively from one type of source. The percentage of people who acquired hypertension medicine exclusively from public pharmacies decreased, from 24.5% in 2013 to 16.2% in 2019; while there was an increase in those obtaining from the Popular Pharmacy program, from 23.5% to 31.4%; as well as for out-of-pocket payment, which rose from 30.9% to 35.5% The percentage of people who acquired diabetes medication exclusively from public pharmacies increased from 7.4% to 18.6% and with out-of-pocket payment increased from 21.6% to 26.8%, while the percentage of those who acquired from the Popular Pharmacy program decreased from 47.2% to 36.4%. The percentage of those who acquired medication from various sources decreased for both hypertension and diabetes. For men, white, and those with higher education, the source of medication acquisition, for both conditions, was mostly by out-of-pocket payment. The high number of medicine acquisition from public sources represents an advance in Brazil's response to the treatment of these conditions, but reducing regional differences still represents a challenge to be overcome by the healthcare system.
本研究旨在根据2013年至2019年的社会人口统计学特征,分析18岁以上人群获取治疗高血压和糖尿病药物的来源。对巴西国家卫生调查的数据进行了分析。大多数有药物治疗诊断和处方的个体报告称仅从一种来源获取药物。仅从公共药房获取高血压药物的人群比例从2013年的24.5%降至2019年的16.2%;而通过大众药房计划获取药物的人群比例从23.5%增至31.4%;自付费用获取药物的人群比例也从30.9%升至35.5%。仅从公共药房获取糖尿病药物的人群比例从7.4%增至18.6%,自付费用获取药物的人群比例从21.6%增至26.8%,而通过大众药房计划获取药物的人群比例从47.2%降至36.4%。从多种来源获取药物的人群比例在高血压和糖尿病患者中均有所下降。对于男性、白人以及受过高等教育的人来说,这两种疾病的药物获取来源大多是自付费用。从公共来源获取大量药物代表了巴西在应对这些疾病治疗方面的进步,但缩小地区差异仍是医疗系统有待克服的挑战。